The global Dementia and Alzheimer’s Disease Market is poised for exponential growth, fueled by the accelerating prevalence of the disease among the world’s aging population and, critically, the recent emergence of Disease-Modifying Therapies (DMTs). These novel treatments, particularly those targeting amyloid beta pathology, are shifting the market landscape from purely symptomatic ma... https://www.databridgemarketresearch.com/